Having an invention is not enough to get a patent. Every patent office applies substantive requirements that your invention must satisfy before protection is granted. This chapter covers the four core patentability requirements -- novelty, non-obviousness (inventive step), utility (industrial applicability), and sufficient disclosure -- with practical examples and jurisdictional comparisons.
The Four Pillars of Patentability
Your invention must clear four fundamental hurdles regardless of which patent office you file with. The terminology varies by jurisdiction, but the underlying concepts are consistent across the more than 150 countries party to the Patent Cooperation Treaty.
| Requirement | U.S. Term | European / WIPO Term | Legal Basis (U.S.) | Legal Basis (EPO) |
|---|---|---|---|---|
| Must be new | Novelty | Novelty | 35 U.S.C. 102 | Art. 54 EPC |
| Must not be obvious | Non-obviousness | Inventive step | 35 U.S.C. 103 | Art. 56 EPC |
| Must be useful | Utility | Industrial applicability | 35 U.S.C. 101 | Art. 57 EPC |
| Must be fully described | Enablement + written description + best mode | Sufficiency of disclosure | 35 U.S.C. 112 | Art. 83 EPC |
The patentability assessment sequence applied by patent examiners
Fail any one of these requirements and your application will be refused. Meet all of them and you have cleared the substantive hurdles -- though procedural and formal requirements must also be satisfied. The sections below examine each requirement in depth.
Novelty: Has It Been Done Before?
Your invention must be new -- it must not have been disclosed to the public anywhere in the world before your filing date (or your priority date, if you claim priority from an earlier application). As WIPO states, the invention "must show some new characteristic which is not known in the body of knowledge that existed prior to the filing date."
What Counts as Prior Art
Prior art is the entire body of publicly available technical knowledge that existed before your filing date. If any single piece of prior art discloses every element of your claimed invention, novelty is destroyed. The scope of what constitutes prior art is broad:
| Type of Prior Art | Examples | Notes |
|---|---|---|
| Published patents and patent applications | Granted patents, published applications, PCT publications in any language, from any country | Patent databases contain over 150 million documents; all are searchable prior art |
| Scientific and technical publications | Journal articles, conference papers, doctoral theses, technical standards, textbooks | Even obscure publications in foreign languages count |
| Commercial products | Products sold or offered for sale anywhere in the world | A product on a store shelf in Tokyo is prior art against a filing in Washington |
| Public use or demonstration | Trade show demonstrations, public testing, open-source software releases | The use must be accessible to the public; private testing under NDA does not count |
| Oral disclosures | Conference presentations, lectures, investor pitches without NDA | Harder to prove, but legally valid prior art in most jurisdictions |
| Online disclosures | Blog posts, YouTube videos, social media posts, forum discussions, preprint servers | Date of public availability is what matters |
The Novelty Trap: A single prior art reference that describes ALL elements of your claimed invention destroys novelty. It does not matter whether the reference is a patent, a product, or a blog post. It does not matter what country it was published in. If someone, somewhere, publicly disclosed your exact invention before your filing date, it is not novel. This is why conducting a thorough prior art search before filing is essential.
How Novelty Is Assessed
Patent examiners assess novelty by comparing each claim in your application against individual prior art references. The key principle: novelty is assessed reference by reference. An examiner cannot combine multiple references to reject a claim for lack of novelty -- that analysis falls under non-obviousness (discussed in the next section).
Example 1 -- Novelty destroyed: You file a patent claim for a bicycle helmet with a built-in LED light strip along the rear edge. An examiner finds a prior art patent published two years earlier that describes a bicycle helmet with a built-in LED light strip along the rear edge. Your claim lacks novelty because the prior art reference discloses every element.
Example 2 -- Novelty preserved: You file a claim for a bicycle helmet with a built-in LED light strip that automatically adjusts brightness based on ambient light sensor data. The examiner finds prior art for helmets with LED strips and separate prior art for ambient light sensors in automotive headlights. No single reference describes your specific combination. Novelty is preserved. (The examiner may still combine these references to argue that the combination is obvious -- but that is a separate analysis.)
Example 3 -- Novelty destroyed by your own disclosure: You present your invention at a trade conference in March, then file a patent application in October. In jurisdictions without a grace period (including Europe), your own conference presentation is prior art that destroys novelty. You have defeated yourself.
Non-Obviousness: The Hardest Hurdle
Novelty asks whether your invention is new. Non-obviousness (called "inventive step" in European and WIPO practice) asks whether your invention is inventive enough. This is consistently the most difficult requirement to satisfy, and it is where most patent applications face their toughest objections.
Would a hypothetical person having ordinary skill in the art -- someone with average knowledge and abilities in the relevant technical field -- find the invention obvious in light of the prior art? If yes, the invention lacks an inventive step and is not patentable, regardless of how novel it is.
The U.S. Approach: Graham v. John Deere Factors
In the United States, non-obviousness is governed by 35 U.S.C. 103 and assessed using the framework established by the Supreme Court in Graham v. John Deere Co. (1966). Examiners and courts evaluate four factors:
- Scope and content of the prior art -- What is already known in the field?
- Differences between the prior art and the claimed invention -- What is new about your invention compared with what exists?
- Level of ordinary skill in the art -- How sophisticated is the typical practitioner in this field?
- Objective indicia of non-obviousness (secondary considerations) -- Evidence such as commercial success, long-felt but unsolved need, failure of others to solve the problem, and skepticism from experts.
Unlike the novelty analysis, an obviousness rejection can combine multiple prior art references. An examiner might argue: "Reference A teaches element X. Reference B teaches element Y. A person of ordinary skill would have been motivated to combine A and B, and the resulting combination is your claimed invention."
The European Approach: Problem-Solution Method
The EPO uses a structured "problem-solution approach" in three steps:
- Identify the closest prior art -- Determine the single most relevant prior art reference (the starting point for the analysis).
- Define the objective technical problem -- Based on the differences between the closest prior art and the claimed invention, formulate the technical problem that the invention solves.
- Assess whether the solution is obvious -- Would a person skilled in the art, starting from the closest prior art and faced with the objective technical problem, have arrived at the claimed solution without exercising inventive skill?
Japan's Patent Office (JPO) uses a similar structured approach to the EPO.
Same Invention, Different Outcomes: The U.S. and European approaches can produce different results for the same invention. A combination of known elements might survive a Graham v. John Deere analysis in the U.S. (especially if the applicant can show commercial success or long-felt need) but fail the EPO's problem-solution approach if the combination is considered an obvious response to a clearly defined technical problem. Conversely, an invention that barely passes the EPO's inventive step threshold might be rejected by a U.S. examiner who finds strong motivation to combine prior art references. This divergence is one reason the same patent application can succeed in one jurisdiction and fail in another.
Comparing Non-Obviousness Standards
| Factor | USPTO (U.S.) | EPO (Europe) | JPO (Japan) |
|---|---|---|---|
| Legal framework | Graham v. John Deere (1966); KSR v. Teleflex (2007) | Problem-solution approach (EPO Guidelines, Part G-VII) | Similar to EPO problem-solution approach |
| Can combine references? | Yes, with motivation to combine | Yes, starting from closest prior art | Yes, with reasoning for combination |
| Secondary considerations | Explicitly part of the analysis (commercial success, long-felt need, etc.) | May be considered but are not central to the method | Considered but less weight than in U.S. |
| Hindsight protection | KSR warns against hindsight bias but allows "common sense" reasoning | Problem-solution method is designed to avoid hindsight | Structured approach limits hindsight |
| Typical difficulty | Moderate to high; TSM test relaxed after KSR (2007) | High; structured approach creates predictability | Moderate; generally follows EPO methodology |
Practical Examples
Example -- Non-obvious in U.S., potentially obvious at EPO: An inventor combines a well-known adhesive with a well-known substrate in a new way to create a reusable mounting strip. In the U.S., if the product achieves unexpected commercial success and fills a long-felt need (consumers have wanted damage-free wall mounting for years), these secondary considerations may support non-obviousness. At the EPO, if a skilled person would have reasonably tried this adhesive-substrate combination as an obvious solution to the known problem of damage-free mounting, the inventive step argument is weaker regardless of commercial success.
Example -- Obvious in U.S., possibly non-obvious at EPO: A software developer finds that applying a known compression algorithm to a specific new data type produces unexpectedly efficient results. A U.S. examiner might combine the known algorithm with the known data type and find the combination obvious under KSR's "common sense" reasoning. At the EPO, if the unexpected efficiency qualifies as a surprising technical effect that a skilled person would not have predicted, the problem-solution approach may find an inventive step.
Utility: Can It Actually Be Used?
The easiest requirement to satisfy. In the United States, the standard is "utility" -- the invention must have a specific, substantial, and credible use. At the EPO and under WIPO practice, the equivalent is "industrial applicability" -- the invention must be capable of being made or used in any kind of industry, including agriculture.
What the Standard Requires
| Jurisdiction | Term | Standard | Key Test |
|---|---|---|---|
| United States | Utility | Specific, substantial, and credible use | Would a person of ordinary skill recognize a real-world application? |
| EPO / Europe | Industrial applicability | Capable of being made or used in industry (Art. 57 EPC) | Can the invention be produced or used in a practical, reproducible way? |
| WIPO / PCT | Industrial application or utility | Capable of being used for an industrial or business purpose beyond a mere theoretical phenomenon | Is there a practical application, or is it purely abstract? |
| Japan | Industrial applicability | Similar to EPO standard | Can it be manufactured or used in industry? |
Most inventions meet this requirement easily. If your invention is a new chemical compound, stating that it can be used as a pharmaceutical agent or an industrial solvent is typically sufficient. If your invention is a machine, its function is self-evident. Rejections on utility grounds involve edge cases:
When Utility Becomes an Issue
Speculative pharmaceutical uses. Claiming a new compound treats a disease without experimental data or scientific basis will be rejected for lacking credible utility.
Research tools with no identified end use. Claiming a gene sequence that "may be useful for future research" without a specific application can fail the utility test, particularly in the U.S., where the use must be specific and substantial.
Perpetual motion machines. An invention that violates known physical laws -- such as a perpetual motion device -- lacks credible utility and will be rejected.
Practical Guidance: If you can describe what your invention does and why someone would want to use it, you almost certainly meet the utility requirement. This is the one patentability hurdle where straightforward, honest description of your invention's purpose is usually sufficient.
Sufficient Disclosure: Can Others Reproduce It?
In exchange for exclusive rights, you must teach the public how to make and use your invention. If your patent document does not contain enough information for a skilled person to reproduce the invention, the application will be rejected -- and even a granted patent can be invalidated on these grounds after the fact.
U.S. Disclosure Requirements
The United States imposes three distinct disclosure obligations under 35 U.S.C. 112:
Enablement. The specification must enable a person of ordinary skill in the art to make and use the full scope of the claimed invention without undue experimentation. The more broadly you claim, the more you must disclose. A claim that covers thousands of chemical variants requires enough examples and guidance for a skilled chemist to make the full range.
Written description. The specification must demonstrate that the inventor actually possessed the claimed invention at the time of filing. This is a separate requirement from enablement -- you can enable someone to make an invention through general guidance while still failing to show that you yourself had the specific invention in hand.
Best mode. The inventor must disclose the best way they know of practicing the invention at the time of filing. While the America Invents Act (2011) removed failure to disclose best mode as a ground for invalidating a patent, it remains a statutory requirement for the application itself.
European Disclosure Requirements
The EPO requires "sufficiency of disclosure" under Article 83 of the European Patent Convention. The application must disclose the invention "in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art." There is no separate "written description" or "best mode" requirement under European law -- a single, unified standard applies.
The EPO's approach focuses on reproducibility. If a skilled person, reading the patent specification and applying common general knowledge, cannot reproduce the invention across the full scope of the claims, the disclosure is insufficient.
| Disclosure Aspect | USPTO (U.S.) | EPO (Europe) |
|---|---|---|
| Core requirement | Enablement (35 U.S.C. 112(a)) | Sufficiency of disclosure (Art. 83 EPC) |
| Must show possession | Yes (written description requirement) | Not a separate requirement; subsumed within sufficiency |
| Best mode required | Yes (statutory requirement, but no longer a basis for invalidation post-2011) | No |
| Consequence of failure | Rejection during prosecution; invalidation in litigation (except best mode) | Rejection during prosecution; revocation post-grant (Art. 138 EPC) |
| Claim scope relationship | Broader claims require more enabling disclosure | Same principle: claims must be supported by the description |
Why Disclosure Failures Are Dangerous
Insufficient disclosure is not just a prosecution problem -- it is a post-grant vulnerability. A competitor who wants to invalidate your patent can argue that the specification does not teach a skilled person how to reproduce the invention. This is a common attack in patent litigation and opposition proceedings.
Example: A biotech company patents a monoclonal antibody defined by its target antigen and binding properties. The specification includes one example antibody but claims a broad genus of antibodies with the same binding characteristics. An opponent argues that a skilled person could not make the full range of claimed antibodies based on a single example. If the patent office or court agrees, the broad claims may be narrowed or the patent revoked.
The Disclosure-Scope Trade-Off: There is a direct tension between claiming broadly (which gives you the widest protection) and disclosing sufficiently (which requires more examples and detail as claim scope increases). Drafting that balances these competing demands is one of the core skills of patent practice. Claims that are broader than what the specification supports are vulnerable to both prosecution rejections and post-grant challenges.
The Grace Period Debate
A grace period allows an inventor to publicly disclose an invention and still file a valid patent application within a specified window. Without a grace period, any public disclosure -- even by the inventor -- before the filing date constitutes novelty-destroying prior art. This divergence has significant strategic implications for anyone seeking global protection.
| Jurisdiction | Grace Period | Duration | Scope |
|---|---|---|---|
| United States | Yes | 12 months | Inventor's own disclosures (and disclosures derived from the inventor) |
| Japan | Yes | 12 months | Inventor's own disclosures; requires a declaration at filing |
| South Korea | Yes | 12 months | Inventor's own disclosures; requires a declaration at filing |
| Canada | Yes | 12 months | Inventor's own disclosures |
| Australia | Yes | 12 months | Inventor's own disclosures |
| Europe (EPO) | Extremely limited | 6 months | Only for disclosures resulting from "evident abuse" or display at officially recognized international exhibitions |
| China | Limited | 6 months | Disclosures at prescribed academic or technical meetings, or evident abuse |
| Brazil | Yes | 12 months | Inventor's own disclosures |
Grace Period and Novelty Standards by Jurisdiction (1 = Restrictive, 10 = Permissive)
The European Position: Absolute Novelty
The EPO applies an absolute novelty standard. If you publish a paper, present at a conference, or post about your invention online before filing your European patent application, that disclosure is prior art -- even though it came from you. The only exceptions are narrow: disclosures resulting from "evident abuse" (someone stealing your idea and publishing it) and displays at officially recognized international exhibitions (a rarely used provision).
Strategic Implications
If you want patent protection in Europe (or China), you must file before any public disclosure. Relying on the U.S. grace period and then trying to file in Europe after a public disclosure will result in the loss of European patent rights. In practice, this means:
- File first, publish second. Always file at least a provisional patent application (in the U.S.) or an initial application establishing a priority date before any public disclosure -- conference presentation, journal submission, product launch, investor pitch, or social media post.
- Use provisional applications strategically. A U.S. provisional patent application is inexpensive and establishes a priority date. File it before any disclosure, then use the 12-month Paris Convention priority period to file internationally.
- NDAs are not a substitute. A non-disclosure agreement keeps information confidential, but if a disclosure does become public despite an NDA, the damage to novelty is done. NDAs reduce risk; they do not eliminate it.
The Safest Rule: Always file before disclosing. Grace periods are a safety net, not a strategy. They do not apply in all jurisdictions, they have complex conditions, and relying on them introduces risk that is entirely avoidable by filing first.
What Is NOT Patentable
Every patent system excludes certain categories of subject matter from patentability. While details vary by jurisdiction, the following are broadly excluded:
| Excluded Category | Rationale | Examples |
|---|---|---|
| Laws of nature | Fundamental scientific principles cannot be owned | Gravity, E=mc2, the speed of light |
| Natural phenomena | Naturally occurring substances and processes are discoveries, not inventions | A naturally occurring mineral, a wild plant species |
| Abstract ideas | Concepts without concrete technical implementation are not inventions | A pure mathematical formula, a philosophical theory |
| Mathematical methods (in isolation) | Mathematics is a tool for all of science; monopolizing formulas would impede progress | An equation for calculating rocket trajectories (but a guidance system using that equation may be patentable) |
| Scientific theories and discoveries | Identifying what already exists in nature is not inventing something new | Discovering a new galaxy, identifying a new subatomic particle |
| Aesthetic creations | These are protected by copyright, not patents | Paintings, sculptures, musical compositions, literary works |
| Perpetual motion machines | Violate known physical laws; lack credible utility | Any device claimed to produce energy from nothing |
| Methods of medical treatment (in some jurisdictions) | Policy-based exclusion to protect physician freedom | Surgical methods, diagnostic methods (EPO excludes these; U.S. does not) |
Context Matters: Many of these exclusions apply only when the subject matter is claimed "as such" or in isolation. A mathematical formula alone is not patentable, but a concrete technical system that applies that formula to solve a real-world problem may well be. The EPO's approach is instructive: the EPC excludes "mathematical methods... as such," meaning that a mathematical method embedded in a technical process can form the basis of a valid patent. The boundary between excluded and patentable subject matter is the focus of Chapter 4.
How excluded subject matter can become patentable when applied in a technical context
Putting It All Together
The four requirements work in concert. A brilliantly novel invention that is not sufficiently disclosed will be rejected. A fully enabled invention that is obvious will be rejected. Understanding how these requirements interact -- and how they differ across jurisdictions -- is essential for building a global patent strategy.
Approximate Distribution of Substantive Rejections at the USPTO (%)
Non-obviousness is where most applications face their toughest fight. Novelty is the second most common ground for rejection. Utility and disclosure issues are comparatively rare but can be devastating -- particularly disclosure failures that surface during litigation years after grant.
Frequently Asked Questions
Novelty and Prior Art
Non-Obviousness and Inventive Step
Disclosure and Filing Strategy
What's Next
You now understand the four substantive requirements every invention must satisfy. Chapter 4 examines the threshold question that comes before these requirements: subject matter eligibility -- which categories of innovation are patentable at all, and how landmark decisions like Alice v. CLS Bank and the EPO's approach to software, AI, and biotechnology define where the boundaries lie.